Low Risk Prostate Cancer Patients Under ‘Watchful Waiting’ Report Good Quality of Life

Low Risk Prostate Cancer Patients Under ‘Watchful Waiting’ Report Good Quality of Life
Patients with low risk prostate cancer on active surveillance for three years experienced similar health related quality of life as men without prostate cancer, both clinically and psychologically, according to the study Prospective Quality of Life in Men Choosing Active Surveillance Compared to Those Biopsied but not Diagnosed with Prostate Cancer,” published in The Journal of Urology . The concept of active surveillance (AS), or watchful waiting, has increasingly emerged in recent years as a viable option for men with low risk prostate cancer who decide not to undergo immediate surgery or radiation therapy. During AS, prostate cancer is carefully monitored for signs of progression. A PSA blood test and digital rectal exam (DRE) are usually administered periodically, along with a repeat biopsy of the prostate at one year and then at specific intervals thereafter. If symptoms develop, or if tests indicate cancer growth, treatment might be warranted. The study investigated the impact of AS on health related quality of life (HRQoL) in men that opt to wait and see, rather than treat the cancer right away with drugs or surgery. "To our knowledge this is the first report of HRQoL outcomes of men on AS for prostate cancer compared to men without prostate cancer in a prospective, multi-institutional study," study author Dr. Christopher R. Porter said in a
Subscribe or to access all post and page content.